TWEAK-Fn14: a promising target for cardio-cerebrovascular diseases and brain-heart syndrome.

Researchers have identified a promising new target for treating heart and brain diseases that often occur together. This review study examined a protein system called TWEAK-Fn14, which becomes overactive when the brain or heart is injured. Scientists found that high levels of these proteins contribute to multiple problems in the brain, including damage to the protective blood-brain barrier, swelling, inflammation, and nerve cell death. In the heart, the same protein system causes problems like inflammation, abnormal cell growth, scarring, and weakened pumping ability. What makes this discovery particularly important is understanding "brain-heart syndrome"—a condition where damage to the brain can worsen heart function and vice versa, creating a harmful cycle. When someone has a stroke, for example, their heart function may deteriorate, and heart problems can increase the risk of brain damage. The TWEAK-Fn14 system appears to play a key role in this two-way connection. For patients considering acupuncture, this research is relevant because traditional Chinese medicine has long recognized the interconnection between organs and treats the body as an integrated system. Acupuncture's ability to reduce inflammation and support overall healing may complement conventional treatments by addressing multiple aspects of cardio-cerebrovascular diseases simultaneously. While this study doesn't directly test acupuncture, it supports the holistic treatment approach that considers both heart and brain health together. If you're considering acupuncture for cardiovascular or neurological concerns, seek a licensed acupuncturist with experience treating these conditions.

This review examines the TWEAK-Fn14 cytokine-receptor axis as a therapeutic target for cardio-cerebrovascular diseases (CCVDs) and brain-heart syndrome (BHS). The study synthesizes evidence showing TWEAK and Fn14 overexpression in both cerebral injury and cardiac dysfunction. In cerebral pathology, this axis mediates blood-brain barrier disruption, edema, neuroinflammation, neuronal apoptosis, and neurodegeneration. Cardiac manifestations include cardiomyocyte proliferation, inflammation, apoptosis, hypertrophy, fibrosis, contractile dysfunction, and ventricular dilatation. The review emphasizes the bidirectional brain-heart relationship in BHS, where cerebral and cardiac pathologies mutually exacerbate outcomes. No specific sample sizes or effect measures are provided as this is a literature review rather than original research. Clinical relevance: The TWEAK-Fn14 pathway represents a unified mechanism linking brain and cardiac pathology, supporting integrated treatment approaches. TCM practitioners should recognize that treatments addressing systemic inflammation and organ interconnection may benefit patients with concurrent cardiovascular and neurological conditions, aligning with traditional concepts of organ system relationships.